GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent - - BioPharm International

ADVERTISEMENT

GMP Compliance for Production of CB.Hep-1 Monoclonal Antibody as a Biological Reagent

16. Valdés R., García J., Reyes B., Muñoz L., Alvarez T., Padilla S., Abrahantes M.C., Zubiaurrez J., Agraz A., Marrero A., "A Very Sensitive Enzyme-linked Immunoabsorbent Assay to Staphylococcal Protein A in the Presence of Immunoglobulins," Biochemical and Biophysical Research Communications, Volume 303, Issue 3, 11 April 2003, Pages 863-867.

17. Hardy E., Martínez E., Diago D., Díaz R., González D., Herrera L., "Large-scale Production of Recombinant Hepatitis B Surface Antigen from Pichia Pastoris," Journal of Biotechnology, 77: 157–167, 2000.

18. Werz W., Hoffmann H., Haberer K., Walter J.K., "Strategies to Avoid Virus Transmissions by Biopharmaceutic Products," 1997.

19. Janet B., Elizabeth M., and Alexander F, "Viral Removal/Inactivation by Purification of Biopharmaceuticals," Biopharm 5, No. 9 (Nov-Dec, 1992): 22-30.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
IMS: Global Spending on Medicines to Rise 30% by 2018
November 24, 2014
Author Guidelines
Source: BioPharm International,
Click here